DIVIDING HIGH-DOSE PPI/SITAFLOXACIN-BASED TRIPLE HELICOBACTOR PYLORI ERADICATION THERAPY IS USEFULNESS AS THIRD-LINE THERAPY IN JAPANESE: PRELIMINARY STUDY

被引：0
|
作者：
Uotani, T. [1 ]
Sugimoto, M. [1 ]
Ichikawa, H. [1 ]
Sahara, S. [1 ]
Furuta, T. [2 ]
机构：
[1] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka 4313192, Japan
[2] Hamamatsu Univ Sch Med, Clin Res Ctr, Hamamatsu, Shizuoka 4313192, Japan
来源：
HELICOBACTER | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [1] Clinical Usefulness of Sitafloxacin-Based Triple Therapy as a Third Line Regimen for Helicobacter pylori Eradication in Japan
    Hirata, Yoshihiro
    Ohmae, Tomoya
    Yanai, Ayako
    Sakitani, Kosuke
    Hayakawa, Yoku
    Yoshida, Shuntaro
    Sugimoto, Takafumi
    Maeda, Shin
    Koike, Kazuhiko
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S879 - S879
  • [2] Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan
    Hirata, Yoshihiro
    Ohmae, Tomoya
    Yanai, Ayako
    Sakitani, Kosuke
    Hayakawa, Yoku
    Yoshida, Shuntaro
    Sugimoto, Takafumi
    Mitsuno, Yuzo
    Akanuma, Masao
    Yamaji, Yutaka
    Ogura, Keiji
    Maeda, Shin
    Koike, Kazuhiko
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (04) : 352 - 355
  • [3] Sitafloxacin-Based Third-Line Eradication of H. pylori
    Suzuki, Hidekazu
    Matsuzaki, Juntaro
    Nishizawa, Toshihiro
    Saito, Yoshimasa
    Hirata, Kenro
    Tsugawa, Hitoshi
    Muraoka, Hiroe
    Hibi, Toshifumi
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S340 - S340
  • [4] Efficacy of triple therapy with esomeprazole, amoxicillin, and sitafloxacin as a third-line Helicobacter pylori eradication regimen
    Hirata, Yoshihiro
    Serizawa, Takako
    Shichijo, Satoki
    Suzuki, Nobumi
    Sakitani, Kosuke
    Hayakawa, Yoku
    Yamada, Atsuo
    Koike, Kazuhiko
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 51 : 66 - 69
  • [5] Triple therapy of vonoprazan, amoxicillin and sitafloxacin is useful third-line regimen for Helicobacter pylori eradication in Japan
    Shimoyama, T.
    Chinda, D.
    Fukuda, S.
    [J]. HELICOBACTER, 2017, 22
  • [6] Efficacy of Triple Therapy of Vonoprazan, Amoxicillin, and Sitafloxacin as the Third-Line Regimen for Helicobacter pylori Eradication in Japan
    Shimoyama, Tadashi
    Higuchi, Naoki
    Oyama, Takao
    Higuchi, Hiroyuki
    Chinda, Daisuke
    Fukuda, Shinsaku
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S498 - S498
  • [7] High Helicobacter pylori cure rate with sitafloxacin-based triple therapy
    Sugimoto, M.
    Sahara, S.
    Ichikawa, H.
    Kagami, T.
    Uotani, T.
    Furuta, T.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (04) : 477 - 483
  • [8] Third-Line Eradication Therapy With Sitafloxacin (STFX) for Helicobacter pylori Infection and Predictive Factors for Successful Eradication
    Kato, Chieko
    Sugiyama, Toshiro
    Fujinami, Haruka
    Kajiura, Shinya
    Nshikawa, Jun
    Minemura, Masami
    Mase, Daisuke
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S579 - S579
  • [9] High-dose versus standard-dose PPI in triple therapy for Helicobacter pylori eradication
    Mitsushige Sugimoto
    David Y Graham
    [J]. Nature Reviews Gastroenterology & Hepatology, 2009, 6 : 138 - 139
  • [10] High-dose versus standard-dose PPI in triple therapy for Helicobacter pylori eradication
    Sugimoto, Mitsushige
    Graham, David Y.
    [J]. NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (03): : 138 - 139
12345